Overview
Dr. Michael T. Melia is an Associate Professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include general infectious diseases, HIV and Lyme disease. He serves as the Director of the Infectious Diseases Fellowship Program. After receiving his medical degree from the Georgetown University School of Medicine, Dr. Melia completed his internal medicine residency, infectious diseases fellowship, and chief medical residency at the Beth Israel Deaconess Medical Center. He joined the Johns Hopkins faculty in 2008. Dr. Melia's academic and research interests center around medical education and coaching in medicine. He is the current Chair of the IDSA Medical Education Community of Practice and is a past Chair of the IDSA Training Program Directors' Committee. In 2015, Dr. Melia was recognized with the Outstanding Achievement in Teaching Award from the Institute for Excellence in Education at the Johns Hopkins University School of Medicine.
Dr. Melia is rated as an Experienced provider by MediFind in the treatment of Nontuberculous Mycobacterial Lung Disease. His top areas of expertise are Lyme Disease, Hepatitis C, Allergic Bronchopulmonary Aspergillosis, and HIV/AIDS.
His clinical research consists of co-authoring 40 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE MAPD
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
10751 Falls Road, Falls Concourse STE 412, Falls Concourse STE 412, Lutherville, MD 21093
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville
Dr. Christopher K. Lippincott is an infectious diseases specialist at the Johns Hopkins University School of Medicine. He is the Clinical Director for the Johns Hopkins Center for Nontuberculous Mycobacteria and Bronchiectasis. He is an expert in the care of patients with mycobacterial infections (NTM and tuberculosis), HIV/AIDS, Lyme disease, and general infectious diseases. He provides teaching to medical students, residents and fellows at the Johns Hopkins University School of Medicine. Dr. Lippincott earned his M.D. at the University of Virginia School of Medicine. He completed his residency at The Ohio State University Wexner Medical Center and infectious diseases fellowship at the University of North Carolina Hospitals. He also earned a Master of Public Health in epidemiology from the University of North Carolina at Chapel Hill in 2013. Prior to joining Johns Hopkins University in 2015, Dr. Lippincott practiced infectious diseases internationally for Medecins Sans Frontieres (Abkhazia, Georgia) and Right to Care (Johannesburg, South Africa). Dr. Lippincott’s research interests include mycobacterial infections (NTM and tuberculosis) and bronchiectasis. Dr. Lippincott is rated as an Advanced provider by MediFind in the treatment of Nontuberculous Mycobacterial Lung Disease. His top areas of expertise are Swimming Pool Granuloma, Nontuberculous Mycobacterial Lung Disease, Osteomyelitis, and Osteomyelitis in Children.
Infectious Diseases Physicians, Inc.
Eric Reines is an Infectious Disease provider in Annandale, Virginia. Dr. Reines is rated as an Advanced provider by MediFind in the treatment of Nontuberculous Mycobacterial Lung Disease. His top areas of expertise are Nontuberculous Mycobacterial Lung Disease, COVID-19, Pneumonia, and Herpetic Stomatitis. Dr. Reines is currently accepting new patients.
Infectious Diseases Physicians, Inc.
David Wheeler is an Infectious Disease provider in Annandale, Virginia. Dr. Wheeler has been practicing medicine for over 44 years and is rated as a Distinguished provider by MediFind in the treatment of Nontuberculous Mycobacterial Lung Disease. His top areas of expertise are Myelitis, HIV/AIDS, AIDS Dementia Complex, and AIDS Dysmorphic Syndrome. Dr. Wheeler is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Lyme DiseaseDr. Melia isAdvanced. Learn about Lyme Disease.
- Experienced
- AIDS Dementia ComplexDr. Melia isExperienced. Learn about AIDS Dementia Complex.
- AIDS Dysmorphic SyndromeDr. Melia isExperienced. Learn about AIDS Dysmorphic Syndrome.
- Allergic Bronchopulmonary Aspergillosis
- ArachnoiditisDr. Melia isExperienced. Learn about Arachnoiditis.
- CellulitisDr. Melia isExperienced. Learn about Cellulitis.
- COVID-19Dr. Melia isExperienced. Learn about COVID-19.